Sofia Friberg Hietala, Ph.D.

Principal Consultant & Team Leader


  • Joined Pharmetheus in 2015, actively working in client projects and as Project Portfolio Team Leader managing a team of MIDD consultants.
  • Expertise includes clinical pharmacology, trial design, and regulatory advice in therapeutic areas such as metabolic diseases, rheumatology, and infectious diseases.
  • Experience as Pharmacokinetics and Pharmacometrics Assessor at the Medical Products Agency, Sweden, where she made scientific assessment of marketing authorization applications, specifically ADME properties, drug-drug interactions, and special populations. Previously, she worked as Senior Clinical Pharmacometrician at AstraZeneca R&D, Sweden, and as Pharmacist at the hospital pharmacy Apoteket SU/Sahlgrenska, Sweden.
  • M.Sc. in Pharmacy (1999) from Uppsala University, Sweden, and Ph.D. in Pharmacology from Gothenburg University, Sweden.
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Exposure–Response Analyses for the MET Inhibitor Tepotinib Including Patients in the Pivotal VISION Trial: Support for Dosage RecommendationsArtemether-Lumefantrine Dosing for Malaria Treatment in Young Children and Pregnant Women: A Pharmacokinetic-Pharmacodynamic Meta-AnalysisA Regulatory View on Dose Finding Studies and on the Value of Dose-Exposure-Response Analysis